Digital Health Blogs News and Updates
As digital health continues to evolve, groundbreaking research and industry insights are shaping the future of medicine. In this edition, we explore how wearable technology is unlocking new understandings of long COVID, the transformative potential of prime editing in genomic research, and the exciting advancements in digitally augmented therapies.
We also bring you exclusive conversations from Frontiers Health 2024, where industry leaders shared their visions for the future—from Chiesi Group’s innovation strategy to MEDICE’s digital health initiatives and the quantum leap from research to diagnostics.
Long COVID remains a significant challenge for the healthcare community, with its varied symptoms making it difficult to diagnose and treat. A recent study published in The Lancet Digital Health sheds new light on this condition using digital health technologies and wearable devices.
Genomic research is entering an exciting new phase with the advent of?large-scale genome randomization techniques. These innovations offer unprecedented insights into the vast noncoding regions of the human genome, which make up?99% of our DNA.
At the recent Frontiers Health conference, Nicole Raleigh, web editor at pharmaphorum, had the opportunity to sit down with Marcus Bates, Vice President and Head of Global Business Development and Global Head of Respiratory at Aptar Digital Health. Their discussion delved into the evolving landscape of digitally augmented therapies and the strides Aptar Digital Health has made over the past year.
领英推荐
At the close of Frontiers Health 2024, we had the pleasure of speaking with Luca Quagliata, VP and Global Head of Medical and Scientific Affairs from Thermo Fisher Scientific.
At the Frontiers Health conference, Eloise McLennan, Deep Dive editor at pharmaphorum, interviewed Fabrizio Conicella, Vice-President Center of Open Innovation & Competence at Chiesi Farmaceutici SpA, to discuss the evolving landscape of pharmaceutical innovation. Conicella shared insights into Chiesi’s innovative strategies and the importance of sustainability in their operations.
At the intersection of traditional pharmaceutical industry practices and modern digital solutions stands a promising strategy: blending in-house expertise with external partnerships with startups. A company that has taken a pioneering role in this area is the MEDICE Health Family.
In Berlin, during the Frontiers Health 2024 conference, Deep Dive editor at pharmaphorum, Eloise McLennan, met with Anna-Maria Heidinger, Head of DSPACE at Daiichi Sankyo Europe, to discuss how they are transforming healthcare through innovative strategies and partnerships.